Back to Journals » Drug Design, Development and Therapy » Volume 11

Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale

Total article views   Abstract views HTML views PDF downloads Totals
10,424 Dovepress* 6,661 2,407+ 1,252 9,068
PubMed Central* 0 1,356 300 1,356
Totals 6,661 3,763 1,552 10,424
*Since 21 March 2017
+Since July 2016

View citations on PubMed Central and Google Scholar